Covidien plc (Ireland), Medtronic, Inc. (U.S.), Biosense Webster, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), and Boston Scientific Corporation (U.S.)
(PRWEB) December 06, 2014
In the ablation technologies market, leading players are adopting the strategies of new product development, new product launches, product enhancements, geographic expansions, agreements, acquisitions, and joint ventures to expand their presence. Market players adopted these strategies to access new technologies, develop novel products, expand their product portfolio, enter into growing markets, and increase their market share. In addition to the top market players, companies such as St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), AngioDynamics, Inc. (U.S.), and AtriCure, Inc. (U.S.) are primarily focused towards launching new ablation devices and acquisitions to widen their product offerings in the market
Get the full report from here @ http://www.marketsandmarkets.com/Market-Reports/ablation-devices-market-791.html
Early buyers will receive 10% of the report customization.
This report studies the global ablation technologies market over the forecast period of 2014 to 2019. The market is expected to reach ~$3.81 billion by 2019, at CAGR of 9.6% from 2014 to 2019. It involves thermal and non thermal ablation technologies. Thermal technologies segment include technologies such as radio-frequency, microwave, ultrasound, hydrothermal, radiation, electrical and light/laser technologies. Under non-thermal ablation technologies, cryoablation and hydro-mechanical technologies are studied.
Talk to Research Analyst @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=791
Ablation procedure refers to a minimally invasive surgical procedure which involves either destruction or removal of diseased or unnecessary tissue with the aim to cure the disease. It provides successful form of surgical option that has gradually becoming a popular alternative over invasive procedure amongst physicians and patients. The principal advantages of these procedures over surgery is short recovery time, short length scars, low risk of infection, less blood loss, and shorter hospital stays.
Factors such as increasing aging population, technological advancements, and rising incidence of chronic diseases such as cardiovascular disorders, cancer, and diseases associated with gynecology, urology and orthopedics, are driving the market. However, the pricing pressures, economic slowdown and unstable reimbursement policies, will restrict the growth of this market to a certain extent.
Ask for PDF Manual @ http://www.marketsandmarkets.com/pdfdownload.asp?id=791
Americas is the biggest market for ablation devices, followed by Europe. However, Asian countries represent the fastest growing markets and factors such as high patient pool, growing preferences to MIS, geographical expansion of market players, increased government investment in healthcare facilities especially in rural areas, westernisation in life style and dietary habits, increasing healthcare expenditure & improving medical insurance plans are driving the ablation devices market.
Report includes company profiles of major players such as Covidien plc (Ireland), Medtronic, Inc. (U.S.), Biosense Webster, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), CONMED Corporation (U.S.), AngioDynamics, Inc. (U.S.), AtriCure, Inc. (U.S.), Smith & Nephew plc (U.K.),and Olympus Corporation (Japan).
Browse Related Reports:
RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019
Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019
MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, and identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/medical-devices